Founded with the mission to revolutionize biologics manufacturing, AthemBio focuses on developing innovative technology solutions to address significant bioprocessing challenges. The company offers automated single-use systems designed to enhance efficiency and reliability in biologics production. Their core vision is to streamline and optimize the manufacturing process, making it more accessible and effective for pharmaceutical companies and research institutions.
AthemBio has garnered attention from notable investors and industry experts due to its groundbreaking approach to bioprocessing. The company's key achievements include the successful deployment of their CORIg and cRUSH systems, which have significantly improved production timelines and reduced costs for their clients. AthemBio's impact on the bioprocessing industry is marked by its commitment to innovation and its ability to deliver practical, scalable solutions that meet the evolving needs of biologics manufacturers.
